SCHEMBL1362532

SCHEMBL1362532

CCCCCCCCC(CO)OCCOC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
ALDH1A1 P00352 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
LPAR1 Q92633 4/20 0.42
LPAR3 Q9UBY5 4/20 0.42
LPAR6 P43657 2/20 0.42
LPAR4 Q99677 2/20 0.42
LPAR5 Q9H1C0 2/20 0.42
LPAR2 Q9HBW0 2/20 0.42
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
DNM1 Q05193 1/20 0.40
CYP2D6 P10635 2/20 0.39
SPHK1 Q9NYA1 1/20 0.39
GMNN O75496 1/20 0.39
POLB P06746 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20729409 0.88 DNM1 (0.45) LMNALPAR1LPAR3LPAR6LPAR4
SCHEMBL4925955 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL5831760 0.86 LMNA (0.50) LMNAALDH1A1CNR1CNR2MAPT
SCHEMBL3391670 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL17817321 0.86 CNR2 (0.51) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL9329951 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL10520454 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL7800390 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL11300731 0.86 CNR2 (0.56) LMNAALDH1A1CNR1CNR2LPAR1
SCHEMBL7191931 0.86 CNR2 (0.51) LMNAALDH1A1CNR1CNR2LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067398-B2 Biodegradable polymers having a pre-determined chirality YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2011-11-29 US disclosed
US-20090318339-A1 Biodegradable polymers having a pre-determined chirality Yissum Research Development Company of The Hebrew Univerisity of Jerusalem (IL) 2009-12-24 US disclosed
EP-1902084-A2 BIODEGRADABLE POLYMERS HAVING A PRE-DETERMINED CHIRALITY Yissum Research Development Company, of The Hebrew University of Jerusalem (IL) 2008-03-26 EP disclosed
WO-2006129320-A2 BIODEGRADABLE POLYMERS HAVING A PRE-DETERMINED CHIRALITY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318339-A1 Biodegradable polymers having a pre-determined chirality PAICS, CD14, PCNA LMNA 23/4885ALDH1A1 1607/4885CNR1 2996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.